Rubius Therapeutics, Inc. Annual Interest Expense in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Rubius Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2016 to 2022.
  • Rubius Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2022 was -$1.13M, a 168% decline year-over-year.
  • Rubius Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2022 was $3.86M, a 40% decline year-over-year.
  • Rubius Therapeutics, Inc. annual Interest Expense for 2022 was $3.86M, a 40% decline from 2021.
  • Rubius Therapeutics, Inc. annual Interest Expense for 2021 was $6.43M, a 53.7% increase from 2020.
  • Rubius Therapeutics, Inc. annual Interest Expense for 2020 was $4.19M, a 61.6% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $3.86M -$2.57M -40% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-27
2021 $6.43M +$2.25M +53.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-27
2020 $4.19M +$1.6M +61.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $2.59M +$2.13M +458% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $464K +$155K +50.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $309K +$160K +107% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $149K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.